4.7 Review

Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease

期刊

JOURNAL OF MOLECULAR BIOLOGY
卷 434, 期 1, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jmb.2021.167220

关键词

ALS; FTD; nuclear-import receptor; FUS; phase separation; chaperone

资金

  1. AstraZeneca post-doctoral fellowship
  2. National Institutes of Health (NIH) [T32GM008275, F31NS111870]
  3. Target ALS
  4. Association for Frontotemporal Degeneration
  5. Amyotrophic Lateral Sclerosis Association
  6. Office of the Assistant Secretary of Defense for Health Affairs through the Amyotrophic Lateral Sclerosis Research Program [W81XWH-20-1-0242, W81XWH-17-1-0237]
  7. G. Harold and Leila Y. Mathers Foundation
  8. Sanofi
  9. NIH [R01GM099836, R21AG061784, R21AG065854, R21NS090205]

向作者/读者索取更多资源

The article discusses the role of nuclear import receptors (NIRs) in nuclear transport and their ability to chaperone and disaggregate NLS-bearing clients in the cytoplasm. It highlights the finding that NIRs can also antagonize aberrant interactions and toxicity of proteins associated with neurodegenerative diseases. Additionally, NIR family members are shown to prevent and reverse liquid-liquid phase separation of specific clients independent of nuclear localization signals (NLS). Strategies to enhance NIR activity or expression for the treatment of neurodegenerative disorders are also discussed.
Nuclear-import receptors (NIRs) engage nuclear-localization signals (NLSs) of polypeptides in the cytoplasm and transport these cargo across the size-selective barrier of the nuclear-pore complex into the nucleoplasm. Beyond this canonical role in nuclear transport, NIRs operate in the cytoplasm to chaperone and disaggregate NLS-bearing clients. Indeed, NIRs can inhibit and reverse functional and deleterious phase transitions of their cargo, including several prominent neurodegenerative disease-linked RNA binding proteins (RBPs) with prion-like domains (PrLDs), such as TDP-43, FUS, EWSR1, TAF15, hnRNPA1, and hnRNPA2. Importantly, elevated NIR expression can mitigate degenerative phenotypes connected to aberrant cytoplasmic aggregation of RBPs with PrLDs. Here, we review recent discoveries that NIRs can also antagonize aberrant interactions and toxicity of arginine-rich, dipeptide-repeat proteins that are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) caused by G4C2 hexanucleotide repeat expansions in the first intron of C9ORF72. We also highlight recent findings that multiple NIR family members can prevent and reverse liquid-liquid phase separation of specific clients bearing RGG motifs in an NLS-independent manner. Finally, we discuss strategies to enhance NIR activity or expression, which could have therapeutic utility for several neurodegenerative disorders, including ALS, FTD, multisystem proteinopathy, limbic-predominant age-related TDP-43 encephalopathy, tauopathies, and related diseases. (c) 2021 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据